Skip to main content
. 2019 Apr 3;17(6):5094–5102. doi: 10.3892/ol.2019.10208

Table III.

Expression of EBI3 and p35 in patients with prostate cancer with different clinicopathological characteristics.

EBI3 expression p35 expression


Clinicopathological characteristic Mean ± standard deviation Mean ± standard deviation n t/F-value P-value t/F-value P-value
Position 2.863 0.0052 2.850 0.0054a
  Cancer 90 8.92±2.52 6.47±2.67
  Adjacent to cancer 90 7.87±2.94 5.42±2.98
Age, years 0.357 0.305 1.031 0.722
  <65 21 9.10±2.36 7.57±3.14
  ≥65 69 8.87±2.58 6.09±2.96
Gleason score F=9.644 0.0002 F=9.300 0.0002b
  ≤6 29 7.38±2.67 5.24±3.27
  7 34 8.82±1.91 6.47±2.21
  8–10 27 9.96±2.01 7.93±1.96
a

P<0.05

b

P<0.001. EBI3, Epstein-barr virus-induced gene 3; p35, interleukin-12A.